Holen Sie sich die Stockscreener-App
3.0001
1.53%
0.0501
Schlusskurs vom Vortag:
$2.95
Offen:
$2.95
24-Stunden-Volumen:
309.50K
Relative Volume:
0.32
Marktkapitalisierung:
$186.14M
Einnahmen:
$267.06M
Nettoeinkommen (Verlust:
$-69.17M
KGV:
-2.6535
EPS:
-1.1306
Netto-Cashflow:
$-22.38M
1W Leistung:
-11.39%
1M Leistung:
-9.79%
6M Leistung:
-45.84%
1J Leistung:
-51.30%
1-Tages-Spanne:
$2.95
$3.04
1-Wochen-Bereich:
$2.73
$3.43
52-Wochen-Spanne:
$2.73
$6.665
Aurora Cannabis Inc. Stock (ACB) Company Profile
Firmenname
Aurora Cannabis Inc.
Sektor
Telefon
-
Adresse
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.005 | 182.73M | 267.06M | -69.17M | -22.38M | -1.1306 |
TAK
Takeda Pharmaceutical Co Adr
|
15.56 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.06 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.04 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
546.14 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-11 | Eingeleitet | TD Cowen | Buy |
| 2024-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-09-21 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-24 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-06-06 | Hochstufung | Stifel | Sell → Hold |
| 2021-09-28 | Hochstufung | MKM Partners | Sell → Neutral |
| 2021-09-03 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-05-14 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-05-14 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-05-11 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-28 | Fortgesetzt | BofA Securities | Neutral |
| 2021-02-12 | Herabstufung | Desjardins | Hold → Sell |
| 2021-02-12 | Herabstufung | MKM Partners | Neutral → Sell |
| 2021-02-12 | Herabstufung | Needham | Hold → Underperform |
| 2020-12-18 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-24 | Hochstufung | Stifel | Sell → Hold |
| 2020-05-22 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-15 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2020-02-27 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-02-25 | Eingeleitet | Needham | Hold |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-14 | Hochstufung | MKM Partners | Sell → Neutral |
| 2020-02-07 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-01-10 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-23 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-09-24 | Eingeleitet | CIBC | Neutral |
Alle ansehen
Aurora Cannabis Inc. Aktie (ACB) Neueste Nachrichten
Aurora Cannabis Inc. stock falls Monday, underperforms market - MarketWatch
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Will Cannabis Stocks on TSX Completion Index Rally on Rate Reset? - Kalkine Media
Aurora Cannabis Is Maintained at Buy by Canaccord Genuity - Moomoo
Aurora Cannabis dips after projecting a revenue decline for FY27 - MSN
Aurora Cannabis Q4 earnings on deck: Here's what to expect - MSN
Aurora Cannabis Price Target Cut to C$8.00/Share From C$10.00 by TD - Moomoo
Aurora Cannabis Is Maintained at Buy by TD - Moomoo
Aurora Cannabis Shares Touch Three-Year Low on Expected Revenue Decline - Moomoo
Aurora Cannabis Inc. stock falls Friday, underperforms market - MarketWatch
Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs - The Globe and Mail
Aurora Cannabis announces full results for 2026 fiscal year - MMJDaily
Aurora Cannabis 4Q Loss Widens on Higher Costs - Moomoo
StockTalk | Cannabis Report: Results, awards, & upgrades | 2026-06-12 | Investing News - Stockhouse
Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To IgnoreBuy (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Stro - GuruFocus
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora (ACB) Q4 2026 Earnings Transcript - The Motley Fool
Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA | 2026-06-11 | Investing News - Stockhouse
Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue - Moomoo
Aurora Cannabis Inc. (ACB:CA) Q4 2026 Earnings Call Transcript Summary - Moomoo
Aurora Cannabis Q4 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: Aurora Cannabis Q4 2026 highlights strong growth By Investing.com - Investing.com Canada
Aurora Cannabis Reports Strong Q4 and Full-Year Results, Stock T - GuruFocus
'Canadian medical products are the highest equity products in the world': Aurora Cannabis CEO - BNN Bloomberg
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quart - GuruFocus
Growing International Sales Not Enough to Offset Canadian Non-Medical Losses for Aurora in FY26 - StratCann
Why Aurora Cannabis Inc stock is plummeting today - Wealth Awesome
Aurora Cannabis (ACB) Reports Strong Q4 Earnings with Revenue Gr - GuruFocus
Aurora Cannabis (ACB) Reports Q4 FY26 Results with Mixed Outlook - GuruFocus
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹ - Investing News Network
Earnings call transcript: Aurora Cannabis Q4 2026 highlights strong growth - Investing.com
Press Release: Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results With Record Annual Revenue and Adjusted EBITDA(1) - Moomoo
Aurora Cannabis Q4 Earnings Call Highlights - MarketBeat
Aurora Cannabis Shares Fall Pre-Bell After Fiscal Q4 Adjusted Net Income Drops - marketscreener.com
Aurora Cannabis FY26 revenue rises 11% to $321 million - scanx.trade
Full Transcript: Aurora Cannabis Q4 2026 Earnings Call - Benzinga
Aurora Cannabis (ACB) Reports Q4 Financial Results and Growth St - GuruFocus
Aurora Cannabis stock dips after Q4 FY26 results (ACB:NASDAQ) - Seeking Alpha
Aurora Cannabis Posts Record FY2026 Medical Revenue, Buys EU-GMP Facility as It Exits Lower-Margin Units - TipRanks
Aurora Cannabis reports record annual revenue, adjusted EBITDA By Investing.com - Investing.com South Africa
Aurora Cannabis reports record annual revenue, adjusted EBITDA - Investing.com
ACB: Q4 FY26 delivered record medical cannabis revenue, strong margins, and global market leadership - TradingView
Canada's Aurora Cannabis Q4 revenue beats estimates - TradingView
Aurora Cannabis : Financial StatementPDF (FS 202631 Q4 2026 Final) - marketscreener.com
Earnings Scheduled For June 11, 2026 - Benzinga
Aurora Cannabis reports record fiscal 2026 revenue of $288.6 million - StreetInsider
Aurora Cannabis (ACB) files 2026 Form 40-F with 58,947,593 shares disclosed - Stock Titan
Finanzdaten der Aurora Cannabis Inc.-Aktie (ACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):